nicorandil has been researched along with Cardiac Remodeling, Ventricular in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 7 (63.64) | 29.6817 |
2010's | 3 (27.27) | 24.3611 |
2020's | 1 (9.09) | 2.80 |
Authors | Studies |
---|---|
Deng, HF; Liu, K; Liu, MD; Ma, H; Wang, KK; Wang, N; Xiao, XZ; Zhu, LL; Zou, J | 1 |
Fan, Y; Feng, X; Li, T; Lv, J; Shi, Z; Sun, C; Sun, D; Wang, S; Yang, Z; Zhao, Z | 1 |
Li, Z; Liu, C; Wang, H; Wang, X; Wang, Y; Xing, Y; Yue, X; Zhang, W; Zhang, X | 1 |
Bi, LQ; Cao, Q; Wang, H; Wang, Q; Xie, WP; Yu, YZ; Zuo, XR | 1 |
Chujo, M; Higgins, CB; Krombach, GA; Lund, GK; Saeed, M; Watzinger, N; Wendland, MF | 1 |
Fujii, K; Ikushima, M; Ito, H; Iwakura, K; Kato, A; Kawano, S; Kimura, R; Masuyama, T; Ogihara, T; Sugimoto, K; Tanaka, K | 1 |
Ichihara, S; Iwase, M; Izawa, H; Murohara, T; Nagasaka, T; Nagata, K; Naoe, T; Noda, A; Obata, K; Xu, J; Yokota, M | 1 |
Horinaka, S; Kobayashi, N; Matsuoka, H; Mori, Y; Yagi, H | 1 |
Abe, N; Fujiwara, T; Hanada, H; Higuma, T; Kameda, K; Matsunaga, T; Okumura, K; Ono, H; Osanai, T; Yokoyama, J | 1 |
Chang, NC; Lee, TM; Lin, MS | 2 |
1 trial(s) available for nicorandil and Cardiac Remodeling, Ventricular
Article | Year |
---|---|
Nicorandil suppresses the increases in plasma level of matrix metalloproteinase activity and attenuates left ventricular remodeling in patients with acute myocardial infarction.
Topics: Acute Disease; Aged; Angiography; Electrophoresis, Polyacrylamide Gel; Female; Gene Expression Regulation; Humans; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinases; Middle Aged; Myocardial Infarction; Nicorandil; Vasodilator Agents; Ventricular Remodeling | 2007 |
10 other study(ies) available for nicorandil and Cardiac Remodeling, Ventricular
Article | Year |
---|---|
Nicorandil alleviates cardiac remodeling and dysfunction post -infarction by up-regulating the nucleolin/autophagy axis.
Topics: Animals; Apoptosis; Autophagy; Hydrogen Peroxide; Mice; Myocardial Infarction; Myocytes, Cardiac; Nicorandil; Nucleolin; Phosphoproteins; RNA-Binding Proteins; Ventricular Remodeling | 2022 |
Nicorandil alleviates myocardial injury and post-infarction cardiac remodeling by inhibiting Mst1.
Topics: Animals; Cardiotonic Agents; Dose-Response Relationship, Drug; Hepatocyte Growth Factor; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Infarction; Nicorandil; Proto-Oncogene Proteins; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Remodeling | 2018 |
Protective Effects of Nicorandil on Cardiac Function and Left Ventricular Remodeling in a Rat Model of Ischemic Heart Failure.
Topics: Animals; bcl-2-Associated X Protein; Cardiotonic Agents; Heart Failure; Heart Ventricles; Male; Myocardial Ischemia; Myocardium; Nicorandil; Rats; Rats, Sprague-Dawley; Ventricular Remodeling | 2018 |
Nicorandil prevents right ventricular remodeling by inhibiting apoptosis and lowering pressure overload in rats with pulmonary arterial hypertension.
Topics: Animals; Antihypertensive Agents; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Enzyme-Linked Immunosorbent Assay; Hypertension, Pulmonary; In Situ Nick-End Labeling; Natriuretic Peptide, Brain; Nicorandil; Proto-Oncogene Proteins c-bcl-2; Rats; Ventricular Remodeling | 2012 |
Left ventricular remodeling after infarction: sequential MR imaging with oral nicorandil therapy in rat model.
Topics: Administration, Oral; Animals; Cardiac Volume; Disease Models, Animal; Female; Heart Ventricles; Magnetic Resonance Imaging; Mesoporphyrins; Myocardial Infarction; Nicorandil; Rats; Rats, Sprague-Dawley; Stroke Volume; Vasodilator Agents; Ventricular Remodeling | 2002 |
Intravenous nicorandil in conjunction with coronary reperfusion therapy is associated with better clinical and functional outcomes in patients with acute myocardial infarction.
Topics: Aged; Angioplasty, Balloon, Coronary; Case-Control Studies; Echocardiography; Female; Humans; Male; Microcirculation; Middle Aged; Myocardial Infarction; Nicorandil; Prognosis; Retrospective Studies; Time Factors; Vasodilator Agents; Ventricular Function, Left; Ventricular Remodeling | 2003 |
Nicorandil promotes myocardial capillary and arteriolar growth in the failing heart of Dahl salt-sensitive hypertensive rats.
Topics: Animals; Antihypertensive Agents; Arteries; Capillaries; Coronary Vessels; Echocardiography; Fibroblast Growth Factor 2; Gene Expression; Heart Failure; Hemodynamics; Hypertension; Male; Myocardium; Nicorandil; Nitric Oxide Synthase Type III; Rats; Rats, Inbred Dahl; Receptors, Vascular Endothelial Growth Factor; Sodium Chloride; Vascular Endothelial Growth Factor A; Ventricular Remodeling | 2005 |
Nicorandil but not ISDN upregulates endothelial nitric oxide synthase expression, preventing left ventricular remodeling and degradation of cardiac function in Dahl salt-sensitive hypertensive rats with congestive heart failure.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Cardiac Volume; Heart Failure; Hypertension; Isosorbide Dinitrate; Male; Nicorandil; Nitric Oxide Donors; Nitric Oxide Synthase Type III; Potassium Channels; Rats; Rats, Inbred Dahl; RNA, Messenger; Up-Regulation; Ventricular Remodeling | 2006 |
Effect of pravastatin on sympathetic reinnervation in postinfarcted rats.
Topics: Animals; Blotting, Western; Cardiac Pacing, Artificial; Coronary Vessels; Disease Models, Animal; GAP-43 Protein; Glyburide; Heart; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; KATP Channels; Ligation; Male; Myocardial Infarction; Myocardium; Neurofilament Proteins; Nicorandil; Norepinephrine; Pinacidil; Polymerase Chain Reaction; Potassium Channel Blockers; Pravastatin; Rats; Rats, Wistar; RNA, Messenger; Sympathetic Nervous System; Tachycardia, Ventricular; Time Factors; Tyrosine 3-Monooxygenase; Ventricular Fibrillation; Ventricular Remodeling | 2007 |
Effect of ATP-sensitive potassium channel agonists on ventricular remodeling in healed rat infarcts.
Topics: Animals; Glyburide; Hemodynamics; Hypertrophy, Left Ventricular; Immunohistochemistry; KATP Channels; Male; Muscle Cells; Myocardial Infarction; Nicorandil; Pinacidil; Rats; Rats, Wistar; Risk Factors; Time Factors; Ventricular Remodeling | 2008 |